Data / Research funding / Wisconsin / Varigen Biosciences Corporation
Varigen Biosciences Corporation: 4 NIH awards ($1.3M), fiscal years 2021 to 2026
Varigen Biosciences Corporation in Middleton, WI is funded under 4 NIH awards ($1.3M) in the NIH and NSF award files, read 2026-11-05. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- XLMBJ8BVWPZ3
- State
- Wisconsin
Awards
4 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Novel Repair Replicase | NIH | National Human Genome Research Institute | 2021 | $399,846 | August 10, 2021 | July 31, 2023 | MEAD, DAVID ALAN | reporter.nih.gov |
| Multi-Omics And Synbio Enabled Discovery Of Antifungal Fernene Triterpenes | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $300,000 | March 15, 2023 | February 28, 2025 | MEAD, DAVID ALAN | reporter.nih.gov |
| Synthetic Biology for Splice Modulating Polyketides | NIH | National Cancer Institute | 2024 | $297,088 | July 1, 2024 | July 1, 2025 | MEAD, DAVID ALAN | reporter.nih.gov |
| A Universal Fungal Transposase System for Increasing Natural Product and Protein Titers | NIH | National Center for Complementary & Integrative Health | 2023 | $295,306 | September 5, 2023 | August 31, 2025 | KNOX, BEN | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2024 | 1 | $297,088 | 0 | $0 |
| 2023 | 2 | $595,306 | 0 | $0 |
| 2021 | 1 | $399,846 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) | PAR-25-255 | NIH | 93.172 | November 5, 2026 | Not listed | Same assistance listing 93.172 as 1 award here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | PAR-25-095 | NIH | 93.172 | November 6, 2026 | $350,000 | Same assistance listing 93.172 as 1 award here |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional) | PAR-26-152 | NIH | 93.395 | November 11, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) | PAR-25-269 | NIH | 93.213 | November 13, 2026 | $350,000 | Same assistance listing 93.213 as 1 award here |
| NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) | PAR-25-270 | NIH | 93.213 | November 13, 2026 | $1.1 million | Same assistance listing 93.213 as 1 award here |
| NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) | PAR-25-271 | NIH | 93.213 | November 13, 2026 | Not listed | Same assistance listing 93.213 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.172 | November 16, 2026 | $50,000 | Same assistance listing 93.172 as 1 award here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | PAR-25-096 | NIH | 93.172 | November 17, 2026 | $200,000 | Same assistance listing 93.172 as 1 award here |
| NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) | PAR-25-267 | NIH | 93.213 | November 17, 2026 | $350,000 | Same assistance listing 93.213 as 1 award here |
| Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) | PAR-25-268 | NIH | 93.213 | November 17, 2026 | Not listed | Same assistance listing 93.213 as 1 award here |
| Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) | PAR-25-274 | NIH | 93.213 | November 17, 2026 | Not listed | Same assistance listing 93.213 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.172 | November 18, 2026 | Not listed | Same assistance listing 93.172 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.172 | November 18, 2026 | Not listed | Same assistance listing 93.172 as 1 award here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.395 | November 20, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.213 | November 23, 2026 | $375,000 | Same assistance listing 93.213 as 1 award here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.172 | November 24, 2026 | Not listed | Same assistance listing 93.172 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.172 | December 3, 2026 | Not listed | Same assistance listing 93.172 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.172 | December 3, 2026 | Not listed | Same assistance listing 93.172 as 1 award here |
Topics of its NIH awards
Updated November 5, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-05). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.